Omalizumab and IgE in the Control of Severe Allergic Asthma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.839011
Abstract: Omalizumab, a human immunoglobulin (Ig)G1 antibody against IgE, is a therapeutic agent for bronchial asthma. The Global Initiative for Asthma guidelines indicate that the use of omalizumab should be considered as an option in step… read more here.
Keywords: control severe; asthma; therapy; ige control ... See more keywords